DB18681ExperimentalCell transplant therapies
Autologous CD34+ hematopoietic stem and progenitor cells expressing adenosine deaminase is an investigational lentiviral gene therapy. It comprises autologous CD34+ hematopoietic stem and progenitor cells (HSPCs) that had been genetically...
Which companies are running trials of Autologous CD34+ hematopoietic stem and progenitor cells expressing adenosine deaminase, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account